NewslettersMammary Cell NewsImatinib Impedes EMT and Notch signaling by Inhibiting p300 Acetyltransferase in Breast Cancer CellsBy Jamie Kang - November 27, 2024018Scientists highlighted the ability of Imatinib to suppress epithelial-mesenchymal transition through modulation of the Notch signaling pathway, offering a novel therapeutic avenue for breast cancer treatment.[Molecular Carcinogenesis]Abstract